“…Variations in or nearby genes related to inflammation, circulation, and cell survival have been suggested in candidate polymorphism studies regarding AKI [7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27]. Additionally, the first hypothesis-free studies in AKI genetic predisposition have been published [28,29,30], with some replicated associations [31]. We chose to test polymorphisms in TNFA (rs1800629 [8,19,21,22,23,24,25,26,27]), IL6 (rs1800796 [24,26] and rs1800795 [19,24,26], rs10499563, rs1474347, rs13306435, rs2069842 and rs2069830), CXCL8 (rs4073 [27]), IL10 (rs1800896 [19,21,23,25,26]), NOS3 (rs2070744 [13,24]), NFKB1A (rs1050851 [32]), AGT (rs699 and rs2493133 [24]), VEGFA (rs2010963 and rs3025039 [27]), EPO (rs1617640 [14]), SUFU (rs10748825 [9]), HIF1A (rs11549465 [15]), PNMT (rs876493 [17]), MPO (rs7208693 [16]), COMT (rs4680 [10,11,12]), HSPB1 (rs2868371 [33]), SFTPD (rs2243639 and rs721917 [34]), HAMP (rs10421768 [35]) and BBS9 (rs10262995 [30]) genes (see d...…”